These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5553720)

  • 21. Abolition of in vitro cytotoxicity of sensitized lymph node cells by regional graft-versus-host reaction. (Immunosuppression-adoptive transfer of immunity).
    Medzihradský J; Novotná L; Altaner C
    Folia Biol (Praha); 1972; 18(1):58-60. PubMed ID: 4401579
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression.
    Kjaergaard J; Shu S
    J Immunol; 1999 Jul; 163(2):751-9. PubMed ID: 10395667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Structural modifications of lymph nodes draining an allogenic graft. Relations with the inflammatory reaction of the graft].
    Simar LJ
    Arch Anat Pathol (Paris); 1973 Mar; 21(1):13-28. PubMed ID: 4703059
    [No Abstract]   [Full Text] [Related]  

  • 25. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 27. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs.
    Ellman L; Green I; Benacerraf B
    J Immunol; 1971 Aug; 107(2):382-8. PubMed ID: 5568769
    [No Abstract]   [Full Text] [Related]  

  • 28. Migratory behavior of lymphocytes during allograft rejection.
    Hoffman RA; Ascher NL; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1102-4. PubMed ID: 7022923
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antigenicity of purified liver parenchyma cells.
    Brent L; Bain AG; Butler R; Horsburgh T; Opara SC; Wood PJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):860-2. PubMed ID: 7022953
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytotoxic antibodies in rabbit anti-leukocyte serum: relation to suppression of transferred lymph node cells.
    Harris S; Ogburn CA; Harris TN
    J Immunol; 1967 Oct; 99(4):721-8. PubMed ID: 6051390
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent and metastatic malignant disease: immunological considerations.
    Carter RL
    Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
    Han IH; Johnson AG; Murphy WH
    J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation of cytotoxic lipid substance in cell-mediated cytotoxicity.
    Okada H; Cyong JC
    Jpn J Exp Med; 1975 Dec; 45(6):533-4. PubMed ID: 1232468
    [No Abstract]   [Full Text] [Related]  

  • 35. Antigen-induced changes in regional lymph nodes of mice. I. Allogeneic cells.
    Ostrowski K; Skopińska E; Sankowski A; Pieńkowski M; Priegnitz A
    Bull Acad Pol Sci Biol; 1968; 16(4):217-23. PubMed ID: 5670038
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.
    Fuller TC; Winn HJ
    Transplant Proc; 1973 Mar; 5(1):585-7. PubMed ID: 4695953
    [No Abstract]   [Full Text] [Related]  

  • 37. CD4+ T cells from mice with intestinal immediate-type hypersensitivity induce airway hyperreactivity.
    Ozdemir C; Sel S; Schöll I; Yildirim AO; Bluemer N; Garn H; Ackermann U; Wegmann M; Barlan IB; Renz H; Sel S
    Clin Exp Allergy; 2007 Oct; 37(10):1419-26. PubMed ID: 17883721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune responses "in vivo" of a population of lymph node cells according to their isogenic or allogenic environment].
    Amiel JL
    Rev Fr Etud Clin Biol; 1966 Dec; 11(10):1023-6. PubMed ID: 5979829
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maturation of cytotoxic effector cells at the site of allograft rejection.
    Ascher NL; Chen S; Hoffman R; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1105-7. PubMed ID: 6973856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.